Precision Biosciences (DTIL) Asset Utilization Ratio (2019 - 2026)

Precision Biosciences (DTIL) has 8 years of Asset Utilization Ratio data on file, last reported at 0.3 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.3, down 22.95% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.3 (down 22.95% YoY), and the FY2025 annual result was 0.24, down 49.2% from the prior year.
• Asset Utilization Ratio grew to 0.3 in Q1 2026 per DTIL's latest filing, from 0.28 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.52 in Q1 2022 and troughed at 0.01 in Q3 2025.
• A 5-year average of 0.27 and a median of 0.3 in 2023 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio jumped 312.5% in 2023, then slumped 98.54% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.1 in 2022, then surged by 205.43% to 0.3 in 2023, then jumped by 57.76% to 0.47 in 2024, then plunged by 41.73% to 0.28 in 2025, then rose by 9.33% to 0.3 in 2026.
• Business Quant data shows DTIL's Asset Utilization Ratio at 0.3 in Q1 2026, 0.28 in Q4 2025, and 0.01 in Q3 2025.